Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers

Sponsor
Indiana University
Study ID
NCT07070804
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • None-placebo — OTHER
    No interventions performed

Study Details

This study will recruit nuMoM2b participants to complete autism screening surveys and will identify 200 children with autism and 400 controls for the study. It will then use existing biospecimens to measure pesticides in maternal urine and metabolomic urine and cord blood predictors of autism risk. All data will then be used to build a predictive model for autism risk at the child's birth.

Key Dates

First listed
Jul 17, 2025
Start date
Sep 1, 2026
Status verified
Nov 2025
Primary completion
Aug 30, 2028
Completion
Aug 30, 2028

Study Design

Enrollment
600 participants (estimated)

Primary Outcome Measure

Diagnosis of autims [ Time Frame: The children are age 11-14 currently. The outcome will be measured during contact with the children in the first 18 months of the project. ]

Find similar trials

Nationwide
Autism spectrum disorder trialsPediatrics trials

Related Studies